why choose us

First received: March 06, 2023

Clinical Trial: Avatrombopag vs. Placebo for CIT in GI Malignancies

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Gastrointestinal Cancer

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Avatrombopag for Persistent Chemotherapy-Induced Thrombocytopenia in Patients With Gastrointestinal Malignancies (ACT-GI)

Brief Summary: The purpose of this study is to compare the efficacy of two study drugs, Avatrobopag versus placebo, to treat persistent Chemotherapy-Induced Thrombocytopenia (CIT) in patients with gastrointestinal (GI) malignancies receiving cytotoxic chemotherapy.The names of the study drugs involved in this study are:Avatrombopag (a thrombopoietin receptor agonist)Matching placebo

Read more